Robert E. Widdop

8.1k total citations
185 papers, 6.7k citations indexed

About

Robert E. Widdop is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Robert E. Widdop has authored 185 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Cardiology and Cardiovascular Medicine, 80 papers in Molecular Biology and 49 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Robert E. Widdop's work include Renin-Angiotensin System Studies (88 papers), Receptor Mechanisms and Signaling (62 papers) and Hormonal Regulation and Hypertension (43 papers). Robert E. Widdop is often cited by papers focused on Renin-Angiotensin System Studies (88 papers), Receptor Mechanisms and Signaling (62 papers) and Hormonal Regulation and Hypertension (43 papers). Robert E. Widdop collaborates with scholars based in Australia, United States and United Kingdom. Robert E. Widdop's co-authors include Tracey A. Gaspari, Emma S. Jones, Antony Vinh, Claudia A. McCarthy, Kate M. Denton, Sanja Bosnyak, Stuart J. McDougall, Barbara K. Kemp‐Harper, Jennifer C. Irvine and Lucinda M. Hilliard and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and PLoS ONE.

In The Last Decade

Robert E. Widdop

180 papers receiving 6.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert E. Widdop 3.7k 2.4k 2.4k 992 693 185 6.7k
Masaru Iwai 2.7k 0.8× 1.8k 0.7× 2.2k 0.9× 931 0.9× 521 0.8× 137 6.1k
Maria José Campagnole‐Santos 5.1k 1.4× 2.6k 1.1× 2.4k 1.0× 771 0.8× 594 0.9× 141 7.3k
Michael J. Katovich 3.1k 0.8× 1.9k 0.8× 1.8k 0.8× 576 0.6× 488 0.7× 161 5.7k
Walter G. Thomas 2.6k 0.7× 1.4k 0.6× 3.8k 1.6× 997 1.0× 1.1k 1.5× 145 7.4k
Robert C. Speth 4.1k 1.1× 2.2k 0.9× 3.0k 1.3× 599 0.6× 1.7k 2.4× 218 7.7k
Eric Lazartigues 2.6k 0.7× 1.4k 0.6× 1.6k 0.7× 660 0.7× 380 0.5× 134 6.0k
Robin L. Davisson 3.6k 1.0× 1.3k 0.5× 2.6k 1.1× 1.9k 1.9× 620 0.9× 117 8.1k
Masaki Mogi 2.1k 0.6× 1.3k 0.5× 1.9k 0.8× 997 1.0× 457 0.7× 179 5.4k
Siew Yeen Chai 3.0k 0.8× 1.4k 0.6× 2.8k 1.2× 777 0.8× 2.0k 2.9× 137 6.2k
Frederick A.O. Mendelsohn 2.8k 0.8× 1.4k 0.6× 2.0k 0.8× 610 0.6× 1.2k 1.7× 106 4.9k

Countries citing papers authored by Robert E. Widdop

Since Specialization
Citations

This map shows the geographic impact of Robert E. Widdop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Widdop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Widdop more than expected).

Fields of papers citing papers by Robert E. Widdop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Widdop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Widdop. The network helps show where Robert E. Widdop may publish in the future.

Co-authorship network of co-authors of Robert E. Widdop

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Widdop. A scholar is included among the top collaborators of Robert E. Widdop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Widdop. Robert E. Widdop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferens, Dorota, Ekaterina Salimova, Philip E. Thompson, et al.. (2024). Insulin Regulated Aminopeptidase (IRAP) Inhibition – A Novel Treatment for Diabetes-Induced Cardiovascular Disease. Heart Lung and Circulation. 33. S480–S480.
2.
Chakraborty, Amlan, Dorota Ferens, Robert E. Widdop, et al.. (2024). Sex- and time-dependent role of insulin regulated aminopeptidase in lipopolysaccharide-induced inflammation. Frontiers in Immunology. 15. 1466692–1466692. 1 indexed citations
3.
Widdop, Robert E., et al.. (2024). Transition from acute kidney injury to chronic kidney disease: mechanisms, models, and biomarkers. American Journal of Physiology-Renal Physiology. 327(5). F788–F805. 19 indexed citations
4.
Wang, Chao, et al.. (2023). The Severity of Isoproterenol-Induced Myocardial Fibrosis and Related Dysfunction in Mice Is Strain-Dependent. Research Explorer (The University of Manchester). 1(2). 10006–10006.
5.
Wannberg, Johan, Jessica Sallander, Maria Backlund, et al.. (2019). A Series of Analogues to the AT2R Prototype Antagonist C38 Allow Fine Tuning of the Previously Reported Antagonist Binding Mode. ChemistryOpen. 8(1). 114–125. 9 indexed citations
6.
Chassagnon, Irène R., Claudia A. McCarthy, Yanni K.‐Y. Chin, et al.. (2017). Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a. Proceedings of the National Academy of Sciences. 114(14). 3750–3755. 166 indexed citations
7.
Lee, Seyoung, Megan A. Evans, Hannah X. Chu, et al.. (2015). Effect of a Selective Mas Receptor Agonist in Cerebral Ischemia In Vitro and In Vivo. PLoS ONE. 10(11). e0142087–e0142087. 27 indexed citations
8.
Sumners, Colin, Masatsugu Horiuchi, Robert E. Widdop, et al.. (2013). Protective arms of the renin–angiotensin‐system in neurological disease. Clinical and Experimental Pharmacology and Physiology. 40(8). 580–588. 66 indexed citations
9.
Gaspari, Tracey A., Iresha Welungoda, Yunshan Hu, et al.. (2011). A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model. Diabetes and Vascular Disease Research. 8(2). 117–124. 163 indexed citations
10.
Irvine, Jennifer C., Barbara K. Kemp‐Harper, & Robert E. Widdop. (2010). Chronic Administration of the HNO Donor Angeli's Salt Does Not Lead to Tolerance, Cross-Tolerance, or Endothelial Dysfunction: Comparison with GTN and DEA/NO. Antioxidants and Redox Signaling. 14(9). 1615–1624. 32 indexed citations
11.
Sampson, Amanda K., Karen M. Moritz, Emma S. Jones, et al.. (2008). Enhanced Angiotensin II Type 2 Receptor Mechanisms Mediate Decreases in Arterial Pressure Attributable to Chronic Low-Dose Angiotensin II in Female Rats. Hypertension. 52(4). 666–671. 125 indexed citations
12.
McDougall, Stuart J., Robert E. Widdop, & Andrew J. Lawrence. (2005). Central autonomic integration of psychological stressors: Focus on cardiovascular modulation. Autonomic Neuroscience. 123(1-2). 1–11. 44 indexed citations
13.
McDougall, Stuart J., Robert E. Widdop, & Andrew J. Lawrence. (2004). Medial prefrontal cortical integration of psychological stress in rats. European Journal of Neuroscience. 20(9). 2430–2440. 54 indexed citations
14.
Jones, Nicole M., Philip M. Beart, James A. Monn, & Robert E. Widdop. (1999). Type I and II metabotropic glutamate receptors mediate depressor and bradycardic actions in the nucleus of the solitary tract of anaesthetized rats. European Journal of Pharmacology. 380(2-3). 129–135. 7 indexed citations
15.
Widdop, Robert E., et al.. (1999). Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats. European Journal of Pharmacology. 381(1). 13–21. 2 indexed citations
16.
Beart, Philip M., et al.. (1997). Effects of the CCKA receptor antagonists SR 27897B and PD140548 on baroreflex function in conscious rats. European Journal of Pharmacology. 337(1). 35–39. 9 indexed citations
17.
Hodgson, Wayne C., et al.. (1996). Vascular reactivity to angiotensin II in blood-perfused kidneys of hypertensive diabetic rats. European Journal of Pharmacology. 310(2-3). 185–191. 8 indexed citations
18.
Widdop, Robert E., et al.. (1995). Lack of a centrally‐mediated antihypertensive effect following acute or chronic central treatment with AT1‐receptor antagonists in spontaneously hypertensive rats. British Journal of Pharmacology. 116(8). 3181–3190. 20 indexed citations
19.
Roberts, R. G. D., et al.. (1992). Effects of capsaicin on cutaneous vasodilator responses in humans. Inflammation Research. 37(1-2). 53–59. 18 indexed citations
20.
Widdop, Robert E., Anthony J.M. Verberne, William J. Louis, & Bevyn Jarrott. (1990). The effect of ketanserin on cardiovascular reflexes in conscious normotensive and spontaneously hypertensive rats. European Journal of Pharmacology. 186(1). 17–28. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaru Iwai Breakdown of academic impact, for papers by Maria José Campagnole‐Santos Breakdown of academic impact, for papers by Michael J. Katovich Breakdown of academic impact, for papers by Walter G. Thomas Breakdown of academic impact, for papers by Robert C. Speth Breakdown of academic impact, for papers by Eric Lazartigues Breakdown of academic impact, for papers by Robin L. Davisson Breakdown of academic impact, for papers by Masaki Mogi Breakdown of academic impact, for papers by Siew Yeen Chai Breakdown of academic impact, for papers by Frederick A.O. Mendelsohn
Rankless by CCL
2026